A phase 2 clinical trial of axitinib and avelumab in patients with recurrent/metastatic adenoid cystic carcinoma (ACC).

被引：0
|
作者：
Ferrarotto, Renata
Bell, Diana
Feng, Lei
Li, Kaiyi
Mott, Frank
Blumenschein, George R.
De Sousa, Luana Guimaraes
Altan, Mehmet
Marques-Piubelli, Mario L.
Dal Lago, Eduardo Andreazza
Kaya, Diana
Godoy, Myrna
Kupferman, Michael Elliot
Glisson, Bonnie S.
El-Naggar, Adel K.
Elamin, Yasir Y.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Thorac Head & Neck Med Oncol, Houston, TX USA
[2] City Hope Natl Med Ctr, Duarte, CA USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostatist, Houston, TX USA
[4] MD Anderson Canc Ctr, Houston, TX USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Head & Neck Med Oncol, Houston, TX USA
[7] Univ Sao Paulo, Sao Paulo, Brazil
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6019
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma
    Ferrarotto, Renata
    Sousa, Luana G.
    Feng, Lei
    Mott, Frank
    Blumenschein, George
    Altan, Mehmet
    Bell, Diana
    Bonini, Flavia
    Li, Kaiyi
    Marques-Piubelli, Mario L.
    Dal Lago, Eduardo A.
    Johnson, Jason J.
    Mitani, Yoshitsugu
    Godoy, Myrna
    Lee, Anna
    Kupferman, Michael
    Hanna, Ehab
    Glisson, Bonnie S.
    Elamin, Yasir
    El-Naggar, Adel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (15) : 2843 - +
  • [2] Axitinib plus avelumab for recurrent/metastatic adenoid cystic carcinoma (R/M ACC): Biomarker analysis of the phase II trial
    Hoff, Camilla Oliveira
    McGrail, Daniel
    Mitani, Yoshitsugu
    Heeke, Simon
    Sousa, Luana
    Santos, Erison
    Siqueira, Juliana Mota
    Li, Kaiyi
    Bell, Diana
    Marques-Piubelli, Mario L.
    Lin, Shiaw-Yih
    El-Naggar, Adel K.
    Ferrarotto, Renata
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Predictive biomarkers of benefit to axitinib plus avelumab in patients with recurrent/metastatic adenoid cystic carcinoma (R/M ACC)
    Hoff, Camilla Oliveira
    McGrail, Daniel
    Heeke, Simon
    de Sousa, Luana Guimaraes
    Li, Kaiyi
    Bell, Diana
    Mitani, Yoshitsugu
    Marques-Piubelli, Mario L.
    Cortez, Maria Angelica
    Lin, Shiaw-Yih
    Elamin, Yasir Y.
    El-Naggar, Adel K.
    Ferrarotto, Renata
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Phase II study of axitinib in patients with progressive, recurrent/metastatic adenoid cystic carcinoma
    Ho, Alan Loh
    Sherman, Eric Jeffrey
    Fury, Matthew G.
    Baxi, Shrujal S.
    Haque, Sofia
    Sima, Camelia S.
    Antonescu, Cristina R.
    Katabi, Nora
    Pfister, David G.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] A phase II study of dovitinib in patients with recurrent or metastatic adenoid cystic carcinoma (ACC).
    Dillon, Patrick Michael
    Petroni, Gina R.
    Moskaluk, Chris
    Fracasso, Paula M.
    Douvas, Michael G.
    Perez, Jose Ricardo
    Varhegyi, Nikole
    Zaja-Milatovic, Snjezana
    Thomas, Christopher Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic Carcinoma
    Desilets, Antoine
    Vos, Joris L.
    Katabi, Nora
    Kuo, Fengshen
    Nadeem, Zaineb
    Linxweiler, Maximilian
    Ostrovnaya, Irina
    Baxi, Shrujal
    Dunn, Lara A.
    Sherman, Eric J.
    Pfister, David G.
    Morris, Luc G. T.
    Ho, Alan L.
    CLINICAL CANCER RESEARCH, 2024, 30 (23) : 5281 - 5292
  • [7] Efficacy of cytotoxic chemotherapy in recurrent/metastatic adenoid cystic carcinoma (ACC)
    Wotman, Michael
    Hoff, Camilla Oliveira
    Bonini, Flavia
    Sawyer, Matthew
    Wang, Kaiwen
    Dal Lago, Eduardo Andreazza
    de Sousa, Luana Guimaraes
    Ferrarotto, Renata
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] A phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent/metastatic adenoid cystic carcinoma (R/M ACC).
    Tchekmedyian, Vatche
    Sherman, Eric Jeffrey
    Dunn, Lara
    Fetten, James Vincent
    Michel, Loren S.
    Kriplani, Anuja
    Morris, Luc
    Ostrovnaya, Irina
    Katabi, Nora
    Haque, Sofia
    Tran, Crystal
    Azar, Julian
    Pfister, David G.
    Ho, Alan Loh
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] A Phase II Study of Dovitinib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma
    Dillon, Patrick M.
    Petroni, Gina R.
    Horton, Bethany J.
    Moskaluk, Christopher A.
    Fracasso, Paula M.
    Douvas, Michael G.
    Varhegyi, Nikole
    Zaja-Milatovic, Snjezana
    Thomas, Christopher Y.
    CLINICAL CANCER RESEARCH, 2017, 23 (15) : 4138 - 4145
  • [10] GLIAVAX: A stratified phase II clinical trial of avelumab and axitinib in patients with recurrent glioblastoma.
    Neyns, Bart
    Ben Salama, Laila
    Awada, Gil
    De Cremer, Jennifer
    Schwarze, Julia Katharina
    Seynaeve, Laura
    Du Four, Stephanie
    Fischbuch, Lydia
    Vanbinst, Anne-Marie
    Everaert, Hendrik
    Michotte, Alex
    Rogiers, Anne
    Theuns, Peter
    Duerinck, Johnny
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345